NCT04277416View on ClinicalTrials.gov

Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Enrolling by invitationOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2032

Conditions
Total Hip ReplacementTotal Hip Arthroplasty
Interventions
DEVICE

Total Hip Arthroplasty

To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.

Trial Locations (1)

97239

Oregon Health Sciences University, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

Ortho Development Corporation

INDUSTRY